SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain
SiteOne Therapeutics宣布获得10000万美元的C轮融资,以推动选择性离子通道调节剂作为非类阿片镇痛治疗。
SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain
SiteOne Therapeutics宣布获得10000万美元的C轮融资,以推动选择性离子通道调节剂作为非类阿片镇痛治疗。
使用浏览器的分享功能,分享给你的好友吧